GENE ONLINE|News &
Opinion
Blog

2025-03-29|

Lab-Created Protein Fragments Linked to Key Features of ALS and Frontotemporal Dementia

by Mark Chiang
Share To

NEWSFLASH

Researchers have identified a mechanism that triggers the accumulation of TDP-43, a protein associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. A study published in Neuron outlines how laboratory-generated fragments of TDP-43 can initiate this buildup, which is considered a hallmark of both neurodegenerative conditions.

The investigation focused on the role of TDP-43 protein “seeds” in promoting pathological changes. Scientists created specific fragments of the protein in controlled lab settings and observed their ability to induce aggregation. This accumulation mirrors what occurs in patients diagnosed with ALS and frontotemporal dementia, where TDP-43 aggregates are commonly found in affected brain regions. The findings provide insight into how these diseases may develop at the molecular level, offering researchers a clearer understanding of their progression.

Date: March, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Alzheimer’s Research: 16 New Susceptibility Genes Identified
2025-02-26
Study Links Antidepressants to Accelerated Cognitive Decline in Dementia Patients
2025-02-26
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top